Arcutis Biotherapeutics, Inc. (ARQT)
23.49
+0.14
(+0.60%)
USD |
NASDAQ |
May 04, 16:00
23.50
+0.01
(+0.04%)
After-Hours: 20:00
Arcutis Biotherapeutics EPS Diluted (Quarterly) : 0.1282 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Repligen Corp. | 0.2345 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Amicus Therapeutics, Inc. | 0.0054 |
| PTC Therapeutics, Inc. | -1.673 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 17.40M |
| Revenue (Quarterly) | 129.50M |
| Total Expenses (Quarterly) | 112.11M |
| Enterprise Value | 2.806B |
| Gross Profit Margin (Quarterly) | 90.97% |
| Profit Margin (Quarterly) | 13.43% |
| Earnings Yield | -0.60% |
| Normalized Earnings Yield | -0.6024 |